MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 9191-9197
Chemistry World
November 27, 2015
Anthony King
Pfizer and Allergan agree mega-merger The deal is being positioned as Irish-based Allergan taking over Pfizer, with the merged entity resident in Ireland for tax purposes. mark for My Articles similar articles
Chemistry World
November 26, 2015
Rebecca Trager
Drug firms to share chemical compound libraries Anglo-Swedish pharmaceutical firm AstraZeneca and French drug company Sanofi have agreed to exchange 210,000 chemical compounds from their respective proprietary libraries. mark for My Articles similar articles
Chemistry World
November 24, 2015
Anthony King
Poor management of antibiotics squandering life-saving drugs A thriving unregulated online market for antibiotics and poor quality products are two problems that are driving antimicrobial resistance worldwide, according to the Review on Antimicrobial Resistance mark for My Articles similar articles
Chemistry World
November 24, 2015
Phillip Broadwith
Toeing the advertising line When it comes to advertising pharmaceuticals, companies have to tread a little more carefully. mark for My Articles similar articles
Fast Company
Neal Ungerleider
Meadow Launches A Cloud Platform For Marijuana Dispensaries A Y Combinator-backed startup is now offering a cloud-based SaaS (software as a service) management platform for California marijuana dispensaries. mark for My Articles similar articles
Chemistry World
November 11, 2015
Maria Burke
Viral cancer therapy approved in the US The first virus therapy to target cancer has been approved in the US. Its main target will be melanoma, the most aggressive form of skin cancer. mark for My Articles similar articles
Chemistry World
November 9, 2015
Phillip Broadwith
AstraZeneca to buy ZS Pharma for ion-balance drugs AstraZeneca has agreed to buy US specialist drug company ZS Pharma for around $2.7 billion in an effort to bolster its drug pipeline. mark for My Articles similar articles
<Older 9191-9197    Return to current articles.